Retivue

What Retivue does

RetiVue, LLC is a privately held medical device company founded in 2021 and headquartered in Charlottesville, Virginia. The company designs and sells the EntireEye family of ultrawidefield retinal imaging cameras, marketed as a low-cost alternative to conventional widefield systems priced at $100,000 or more. The product line consists of the EntireEye Desktop Gen 2.0 ($12,995) for clinic use with a 160° field of view and 20MP Sony CMOS sensor, and the EntireEye Portable Gen 2.0 (starting at approximately $10,000) in a 1.5 lb handheld touchscreen form factor supporting up to 205° field of view for premature infants. Supporting products include the Adult Model Eye Kit ($795) and Premature Infant Model Eye Kit ($995) for training, and lithium battery accessories ($95-$99) for off-grid operation.

The technology combines a patented optical design with full-spectrum white-light illumination, non-mydriatic imaging (no pupil dilation required, 3.0mm minimum pupil), and automated focus-and-capture functionality. Software is custom-built with GPU/CUDA optimization and supports DICOM export for Epic, NextGen, and PACS integration. RetiVue's go-to-market blends direct enterprise sales to ophthalmologists, optometrists, hospitals, and NICUs with humanitarian deployments through nonprofit partners including FOCUS, FANLYC, and Fundacion Vision in Haiti, Panama, Paraguay, Rwanda, and Tanzania. Revenue is generated exclusively through one-time hardware purchases via a Shopify e-commerce storefront with US-only domestic shipping.

The company is founder-owned and bootstrapped under CEO Dr. Paul Yates, a practicing vitreoretinal specialist, with a 6-person team supplemented by a Head of Sales and Marketing hired in July 2024. The only disclosed non-dilutive funding is a Phase I NIH SBIR grant through the National Eye Institute awarded in May 2024 to develop a 3D endoscopy solution for vitreoretinal surgery, signaling planned product expansion beyond retinal imaging.

Name

Retivue

Legal name

RetiVue, LLC

Website

https://retivue.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

RetiVue, founded in 2021 and based in Charlottesville, Virginia, designs and sells affordable ultrawidefield retinal imaging cameras (EntireEye Desktop and Portable, $10,000-$13,000) targeting ophthalmology practices, NICUs, and humanitarian screening programs in underserved regions.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Imaging Devices

NAICS

Ophthalmic Goods Manufacturing (339115)

SIC

Ophthalmic Goods (3851), Optical Instruments & Lenses (3827)

akta.pro primary industry

Optical Dispensing & Eyewear Devices (Frames, Lenses, Lens Edging/Finishing Equipment) (HLAHAJAD)

Keywords

• Retinal imaging devices
• Ultrawidefield fundus cameras
• Ophthalmic medical equipment
• Diabetic retinopathy screening
• Neonatal eye imaging

Headquarters

HQ city

Charlottesville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Retinal Imaging Hardware Sales: One-time purchase of EntireEye Desktop and Portable retinal imaging cameras. Includes 3-year warranty and software upgrades. Accessories include batteries and lens modules sold separately.
2. Training Model Eyes: Sale of anatomically accurate model eyes for training purposes including Adult Model Eye Kit and Premature Infant Model Eye Kit.
3. Accessories: Sale of lithium batteries and other accessories for portable and outlet-free operation.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

RetiVue designs, manufactures, and sells the EntireEye retinal imaging system — ultrawidefield (up to 205°) non-mydriatic cameras in desktop and portable form factors, supported by photorealistic training model eyes and battery accessories. The systems deliver true-color single-capture retinal images for ophthalmologists, optometrists, hospitals, NICUs, and nonprofit screening programs at price points starting near $10,000, well below competing widefield cameras priced above $100,000.

Product overview

Retivue offers the EntireEye Imaging System, a portfolio of retinal imaging products designed for affordable, high-definition ultrawidefield eye screening across patient populations from premature infants to older adults. The portfolio comprises two core product lines: the EntireEye Desktop (Gen 2.0) for stationary clinic use offering 160° field of view with 20MP resolution, and the EntireEye Portable (Gen 2.0 and Gen 1.5) for handheld mobile screening up to 205° field of view in infants. Supporting the imaging systems are photorealistic 3-D training model eyes (Adult and Premature Infant variants) and lithium battery accessories enabling outlet-free field deployments. All core products share common features including non-mydriatic (no dilation required) operation, automated focus and capture, on-screen guided alignment, DICOM export for EMR/PACS integration, and compatibility with NextGen and Epic EMR platforms. The product strategy centers on affordability and portability to enable tele-ophthalmic screening in underserved populations.

Differentiator

Problem solved

Functional benefit

Products and services

• EntireEye Desktop Gen 2.0 Ultrawidefield retinal imaging desktop camera combining 160° field of view with 20MP image quality in an all-in-one design. Non-mydriatic, automated focus and capture, DICOM export for Epic/NextGen EMR and PACS, modular lens options, and 3-year warranty. Sold to ophthalmology practices, hospitals, and clinics for diabetic retinopathy screening and retinal documentation.
• EntireEye Portable Gen 2.0 Handheld ultrawidefield retinal imaging device in a portable touchscreen form-factor weighing 1.5 lb. Supports non-mydriatic imaging up to 205° field of view for infants and 135° for adults, with removable eyecup and disposable silicone spacers, automated focus and capture, and selfie imaging capability. Designed for field deployments, NICU bedside ROP screening, and humanitarian missions.
• Adult Model Eye Kit Photorealistic, anatomically accurate 3-D model eye for training and demonstration with normative measurements including 5.5mm pupil, correct corneal and lens curvatures/refractive power, anterior/posterior chamber dimensions, and axial lengths. Kit includes model eye with tripod mount, magnetic base, full-spectrum white light illumination, tripod ball head, and clamp arm for slit lamp mounting. Sold to medical training institutions and ophthalmology practices.
• Premature Infant Model Eye Kit Silicone premature infant doll with a photorealistic infant model eye for training healthcare professionals in retinal imaging techniques specific to premature infants. Sold to NICU training programs and ophthalmology residency programs for ROP screening simulation.
• 12V in / 9V out Lithium Battery for Outlet-Free Operation Clinic-ready lithium power pack delivering regulated 9V output from a 12V input for mobile RetiVue screenings without grid power. Includes battery pack charger cord. Sold as an accessory for portable field deployments.
• 12V Lithium Battery for Outlet-Free Operation High-capacity lithium battery delivering 12V rail power to keep RetiVue systems running off-grid for field deployments. Sold as an accessory for the EntireEye Portable.
• EntireEye Portable Gen 1.5 Compact, portable handheld ultra-widefield retinal imaging device with true color full-spectrum capture, supporting 205° baby lens and 160°/125° adult lens modules, non-contact operation without gel, removable eyecup with disposable spacers, internal fixation with selfie imaging, foot pedal for manual control, and optional desktop base. Available on sale at $5,995 (regular $9,995) as the previous generation.

Quantifiable outcome

• 205° field of view captures nearly 4x the retinal area of conventional baby eye screening cameras in a single image
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• FANLYC (Fundación Amigos del Niño con Leucemia y Cáncer)coreStrategic or Co-development Partner · 6 January 2025Panamanian nonprofit focused on children with cancer seeking new healthcare delivery approaches. RetiVue partnered with Dr. Roberto Yee's team at FANLYC to introduce the EntireEye WideField Portable Camera for retinoblastoma screening. Dr. Yates provided remote guidance from Virginia while FANLYC team operated the device in Panama's operating room.
• FOCUS TanzaniaminorStrategic or Co-development Partner · 1 April 2024RetiVue helped establish a new ROP and adult screening program with FOCUS in Tanzania in April 2024.
• Fundacion VisioncoreStrategic or Co-development Partner · 1 January 2023Partnership established in 2023 to create a training program for ROP screening in Paraguay, with the goal of developing a training center for Latin America.
• FOCUS RwandaminorStrategic or Co-development Partner · 1 January 2022RetiVue helped FOCUS provide an ROP screening solution for Rwanda in 2022.
• FOCUS (Foundation for Ophthalmological Care from the United States)coreStrategic or Co-development Partner · 1 April 2021FOCUS is a nonprofit led by Dr. Dan Alter that provides direct patient care and trains Haitian medical staff at Hôpital d l'Universite d'Etat d'Haiti (HUEH). Dr. Alter took the RetiVue Portable prototype on a mission trip in April 2021, successfully screening Haitian infants for ROP with real-time guidance from Dr. Yates in Virginia via secure internet feed.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Emerging players

• Phelcom Technologies: Brazilian startup offering portable, AI-enabled retinal cameras (Eyer) for diabetic retinopathy and ROP screening at low cost. Overlaps with RetiVue on portability, price, and global-health deployment model.
• CenterVue (now iCare): Portable fundus imaging (Eidon, DRS) targeting screening and primary-care optometry. Closest portable-form-factor competitor to RetiVue's EntireEye Portable in the screening use case.
• Forus Health: India-based portable retinal imaging company (3nethra) focused on affordable screening for diabetic retinopathy and ROP in emerging markets — directly comparable mission and price point to RetiVue's underserved-population focus.

Direct peers

• Optos: Market-leading ultrawidefield retinal imaging company (now part of Nikon Healthcare), offering the Daytona and California devices that compete head-to-head with RetiVue's EntireEye system. Both target the same ophthalmology and optometry customer base with single-capture widefield imaging.
• Natus Medical (Retcam): Sells the Retcam widefield retinal imaging system used in NICUs for ROP screening — exactly RetiVue's primary use case. RetiVue's new Head of Sales previously ran global Retcam sales at Natus/Clarity, underscoring direct competitive overlap.
• Clarity Medical Systems: Original developer of the Retcam widefield ROP system (acquired by Natus). RetiVue's Head of Sales previously led global Retcam sales here, indicating direct competitive overlap in pediatric/ROP imaging.

Broad incumbents

• iCare (Revenio Group): Ophthalmic diagnostic device company with fundus imaging, tonometry, and perimetry products sold to optometrists and ophthalmologists — overlapping customer base with RetiVue.
• Carl Zeiss Meditec: Global ophthalmic devices leader (VISUCAM, CLARUS 500 widefield fundus, Humphrey fields). Competes with RetiVue in ophthalmology clinics and hospitals with a much broader product and service footprint.
• Topcon Healthcare: Major ophthalmic instrument and imaging company (TRC-NW8F, Maestro, DRI OCT). Targets the same optometry/ophthalmology customer base with multi-modal retinal imaging at higher price points.
• Heidelberg Engineering: Established ophthalmic imaging incumbent offering a broad portfolio (SPECTRALIS OCT, HRT, Retina Workplace) used by the same retina specialists RetiVue targets. Overlaps in clinical imaging workflows rather than portable ROP niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCR11vC02YOn2AwExPp-ITag
• Facebookfacebook.com/pages/category/Medical-Company/RetiVue-LLC-135202713240474
• LinkedInlinkedin.com/company/retivue

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retivue